Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,193–2,200 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Invivyd Inc. VYD2311 - (LIBERTY) COVID vaccine Phase 3 Ongoing Intravenous COVID-19
Invivyd Inc. PEMGARDA (VYD222 (pemivibart)) - (CANOPY) COVID-19 Prevention Phase 3 Data Released Intravenous COVID-19
Invivyd Inc. ADG20 - (STAMP) COVID-19 (treatment) NDA Filing Ongoing Intramuscular COVID-19
Invivyd Inc. ADG20 - (EVADE) COVID-19 (prevention) Phase 2/3 Data Released Intramuscular COVID-19
Invivyd Inc. ADG 20 Healthy Volunteers Phase 2/3 Data Released Intravenous N/A
IO Biotech Inc. IO102-IO103 - (IOB-032) Squamous cell carcinoma of the head and neck (SCCHN) Phase 2 Trial Completed Intravenous Oncology
IO Biotech Inc. IO102-IO103 with pembrolizumab - (basket trial) Metastatic solid tumors Phase 2 Enrollment Conclusion Intravenous Oncology
IO Biotech Inc. IO102-IO103 in combination with pembrolizumab - (IOB-022) Non-small cell lung cancer (NSCLC) Phase 2 Data Released Intravenous Oncology